Robert A. Bradway

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.[1]

Robert A. Bradway
NationalityAmerican
Alma materAmherst College
Harvard University
OccupationChairman and Chief Executive Officer of Amgen

Education

Bradway holds a B.S. degree in Biology from Amherst College and an MBA from Harvard University.[2]

Career

Bradway was the MD for banking department and corporate finance Europe, for Morgan Stanley in London. In 1985, he joined Morgan Stanley in New York as a health care industry investment banker. He then moved to London in 1990 where he served as head of Morgan Stanley's international health care investment banking activities. He subsequently, assumed responsibility for corporate finance management.[3]

Bradway joined Amgen in 2006 as vice president, Operations Strategy, and served as executive vice president and chief financial officer from April 2007 to May 2010.[4] He was its president and chief operating officer from May 2010 to May 2012.[5] In 2011, he was appointed to the Amgen board of directors.[6]

Bradway serves on the board of directors of the Norfolk Southern Corporation and Boeing.[7] He gave the 2016 commencement speech at the Keck Graduate Institute, which is part of The Claremont Colleges.[8] He gave the 2017 commencement speech at the UCLA Anderson School of Management, where he serves on the board of trustees and on the board of the Leonard D. Schaeffer Center for Health Policy and Economics.[9]

He is the chairman of the CEO Roundtable on Cancer and a member of the American Heart Association CEO Roundtable.[10]


References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.